HK1087409A1 - Novel heteroaryl derivative - Google Patents
Novel heteroaryl derivativeInfo
- Publication number
- HK1087409A1 HK1087409A1 HK06109338.6A HK06109338A HK1087409A1 HK 1087409 A1 HK1087409 A1 HK 1087409A1 HK 06109338 A HK06109338 A HK 06109338A HK 1087409 A1 HK1087409 A1 HK 1087409A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- optionally substituted
- heteroaryl derivative
- heteroaryl
- novel heteroaryl
- single bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003274684 | 2003-07-15 | ||
| PCT/JP2004/010282 WO2005012245A1 (fr) | 2003-07-15 | 2004-07-13 | Nouveau dérivé d'hétéroaryle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1087409A1 true HK1087409A1 (en) | 2006-10-13 |
Family
ID=34113749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06109338.6A HK1087409A1 (en) | 2003-07-15 | 2006-08-22 | Novel heteroaryl derivative |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7425642B2 (fr) |
| EP (1) | EP1647546B1 (fr) |
| JP (2) | JP4820169B2 (fr) |
| KR (1) | KR101086654B1 (fr) |
| CN (1) | CN100516041C (fr) |
| AT (1) | ATE556051T1 (fr) |
| CA (1) | CA2531064C (fr) |
| ES (1) | ES2383895T3 (fr) |
| HK (1) | HK1087409A1 (fr) |
| MX (1) | MXPA06000539A (fr) |
| TW (1) | TW200523249A (fr) |
| WO (1) | WO2005012245A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1837329A4 (fr) * | 2005-01-14 | 2009-08-05 | Dainippon Sumitomo Pharma Co | Nouveau derive d'heteroaryle |
| US20060241073A1 (en) * | 2005-04-20 | 2006-10-26 | Wanders Ronaldus J A | Means and methods for counteracting fatty acid accumulation |
| US8273738B2 (en) | 2006-09-05 | 2012-09-25 | Kyowa Hakko Kirin Co., Ltd. | Imidazole derivatives |
| US20090054450A1 (en) * | 2007-06-19 | 2009-02-26 | Ironwood Pharmaceuticals, Inc. | Compositions and methods of use for treating or preventing lipid related disorders |
| WO2010050422A1 (fr) | 2008-10-31 | 2010-05-06 | 大日本住友製薬株式会社 | Agent destiné au traitement du diabète |
| MX2011010030A (es) * | 2009-03-26 | 2011-10-11 | Dainippon Sumitomo Pharma Co | Medicamento novedoso para el tratamiento del deterioro cognitivo. |
| JPWO2011002012A1 (ja) * | 2009-07-01 | 2012-12-13 | キッセイ薬品工業株式会社 | Ｓｇｌｔ１阻害薬とインスリン抵抗性改善薬を組み合わせてなる医薬 |
| AU2011210765A1 (en) | 2010-01-28 | 2012-09-13 | President And Fellows Of Harvard College | Compositions and methods for enhancing proteasome activity |
| WO2012007500A2 (fr) | 2010-07-15 | 2012-01-19 | Bayer Cropscience Ag | Nouveaux composés hétérocycliques servant d'agents de lutte contre les nuisibles |
| SI2707101T1 (sl) | 2011-05-12 | 2019-06-28 | Proteostasis Therapeutics, Inc. | Regulatorji proteostaze |
| US10266490B2 (en) * | 2012-03-16 | 2019-04-23 | Georgetown University | Radioprotector compounds |
| WO2014116228A1 (fr) | 2013-01-25 | 2014-07-31 | President And Fellows Of Harvard College | Inhibiteurs de l'usp14 utilisables en vue du traitement ou de la prévention d'infections virales |
| WO2015073528A1 (fr) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Composés renforçant l'activité des protéasomes |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2752361A1 (de) * | 1977-11-24 | 1979-06-07 | Troponwerke Gmbh & Co Kg | Neue indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| JP2001514631A (ja) | 1997-03-07 | 2001-09-11 | ノボ ノルディスク アクティーゼルスカブ | ４，５，６，７−テトラヒドロ−チエノ［３，２−ｃ］ピリジン誘導体類、それらの製造方法及び使用 |
| US6177443B1 (en) * | 1997-03-07 | 2001-01-23 | Novo Nordisk A/S | 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use |
| JP2002121186A (ja) | 2000-05-22 | 2002-04-23 | Takeda Chem Ind Ltd | チロシンホスファターゼ阻害剤 |
| US6911468B2 (en) * | 2000-05-22 | 2005-06-28 | Takeda Chemical Industries, Ltd. | Tyrosine phosphatase inhibitors |
| SI1294724T1 (sl) * | 2000-06-26 | 2006-08-31 | Pfizer Prod Inc | Pirolo(2,3-d)primidinske spojine kot imunosupresivna sredstva |
| ATE401306T1 (de) * | 2001-04-19 | 2008-08-15 | Dainippon Sumitomo Pharma Co | Pyrrolderivat |
| JP2003171275A (ja) | 2001-12-11 | 2003-06-17 | Sumitomo Pharmaceut Co Ltd | ＰＰＡＲδアゴニスト |
| WO2004048341A1 (fr) * | 2002-11-28 | 2004-06-10 | Sumitomo Pharmaceuticals Co., Ltd. | Nouveau derive heteroaryle |
-
2004
- 2004-07-13 ES ES04747746T patent/ES2383895T3/es not_active Expired - Lifetime
- 2004-07-13 KR KR1020067000907A patent/KR101086654B1/ko not_active IP Right Cessation
- 2004-07-13 EP EP04747746A patent/EP1647546B1/fr not_active Expired - Lifetime
- 2004-07-13 CN CNB2004800262352A patent/CN100516041C/zh not_active Expired - Fee Related
- 2004-07-13 MX MXPA06000539A patent/MXPA06000539A/es active IP Right Grant
- 2004-07-13 US US10/563,361 patent/US7425642B2/en not_active Expired - Fee Related
- 2004-07-13 AT AT04747746T patent/ATE556051T1/de active
- 2004-07-13 WO PCT/JP2004/010282 patent/WO2005012245A1/fr active Application Filing
- 2004-07-13 CA CA2531064A patent/CA2531064C/fr not_active Expired - Fee Related
- 2004-07-13 JP JP2005512472A patent/JP4820169B2/ja not_active Expired - Fee Related
- 2004-07-15 TW TW093121149A patent/TW200523249A/zh not_active IP Right Cessation
-
2006
- 2006-08-22 HK HK06109338.6A patent/HK1087409A1/xx not_active IP Right Cessation
-
2008
- 2008-07-15 US US12/173,792 patent/US20080306275A1/en not_active Abandoned
-
2011
- 2011-07-07 JP JP2011151138A patent/JP2011251974A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20060194857A1 (en) | 2006-08-31 |
| TWI331142B (fr) | 2010-10-01 |
| EP1647546B1 (fr) | 2012-05-02 |
| KR101086654B1 (ko) | 2011-11-24 |
| ATE556051T1 (de) | 2012-05-15 |
| JP2011251974A (ja) | 2011-12-15 |
| MXPA06000539A (es) | 2006-03-30 |
| ES2383895T3 (es) | 2012-06-27 |
| CA2531064A1 (fr) | 2005-02-10 |
| EP1647546A1 (fr) | 2006-04-19 |
| TW200523249A (en) | 2005-07-16 |
| US20080306275A1 (en) | 2008-12-11 |
| US7425642B2 (en) | 2008-09-16 |
| JP4820169B2 (ja) | 2011-11-24 |
| JPWO2005012245A1 (ja) | 2006-09-14 |
| EP1647546A4 (fr) | 2008-07-23 |
| CN100516041C (zh) | 2009-07-22 |
| WO2005012245A1 (fr) | 2005-02-10 |
| CA2531064C (fr) | 2012-05-22 |
| KR20060040681A (ko) | 2006-05-10 |
| CN1849303A (zh) | 2006-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1087409A1 (en) | Novel heteroaryl derivative | |
| TW200510441A (en) | Novel compounds | |
| WO2004106343A3 (fr) | Molecules et analogues de la famille agelastatine d'alkaloides antitumuraux et inhibiteurs de gsk-3? | |
| EP1736467A4 (fr) | Nouveau derive sulfonamide | |
| DE60140456D1 (de) | Aza heterocyclische derivate und ihre therapeutische verwendung | |
| EP1541570A4 (fr) | Nouvelle substance active sur le plan physiologique | |
| WO2008108386A1 (fr) | Composition pharmaceutique | |
| WO2003072553A8 (fr) | N-aryl-2-oxazolidinone-5-carboxamides et leurs derives et utilisation de ces composes comme antibacteriens | |
| WO2004085385A3 (fr) | Ligands de recepteurs de cannabinoides | |
| EP1837329A4 (fr) | Nouveau derive d'heteroaryle | |
| CY1105047T1 (el) | Ενωσεις πυριδοπυριμιδινονης, η μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| IL166513A0 (en) | Lamellarin derivatives and pharmaceutical compositions containing the same | |
| IL169257A0 (en) | Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents | |
| MY138826A (en) | 2,7-substituted indoles | |
| WO2005077926A3 (fr) | Composes chimiques | |
| EP1167369A4 (fr) | Nouveaux derives de thiazolobenzimidazole | |
| FI935799A0 (fi) | Arylsubstituerade heterocykliska foereningar | |
| WO2001055126A3 (fr) | Synthese de derives 9-dihydro-paclitaxel hydrosolubles de 9-dihydro-13-acetylbaccatine iii | |
| DK0604355T3 (da) | Arylsubstituerede heterocykliske forbindelser | |
| WO2006052430A3 (fr) | Intermediaires opiaces et procedes de synthese | |
| WO2004048381A3 (fr) | Nouveaux composes de pyrazoloazepine utilises en tant qu'agents pharmaceutiques | |
| AU5576298A (en) | Novel amide derivatives and medicinal compositions thereof | |
| IS8034A (is) | Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla | |
| WO2004024755A3 (fr) | Derives sarcolysyl et procede de fabrication |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160713 |